Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive

Conclusions Women on DNG/EE COC continuous regimen reported a reduction of endometriosis-associated pelvic pain and there was an improvement of their sexual activity and their QoL that was better than the DNG/EE 21/7 conventional regimen.

http://link.springer.com/10.1007/s40618-016-0460-6

Source: Journal of Endocrinological Investigation - March 28, 2016 Category: Endocrinology Source Type: research